Mining the Prognostic Value of HNRNPAB and Its Function in Breast Carcinoma

Table 3

The expression of HNRNPAB and survival rates in BC patients.

Dataset	Endpoint	Probe ID	Sample number	Cox value	HR	95% CI
GSE4922-GPL96	Disease free survival	201277_s_at	249	0.000006	4.03	2.21-7.36
GSE3494-GPL96	Disease specific survival	201277_s_at	236	0.000017	5.67	2.57-12.51
GSE3143	Overall survival	38094_at	158	0.000183	5.84	2.32-14.72
GSE1456-GPL96	Relapse free survival	201277_s_at	159	0.001363	4.01	1.71-9.39
GSE12276	Relapse free survival	201277_s_at	204	0.001956	2.16	1.33-3.51
GSE6532-GPL570	Relapse free survival	201277_s_at	87	0.002211	6.00	1.90-18.89
GSE6532-GPL570	Distant metastasis free survival	201277_s_at	87	0.002211	6.00	1.90-18.89
GSE9195	Distant metastasis free survival	201277_s_at	77	0.003327	25.17	2.92-216.77
GSE1456-GPL96	Disease specific survival	201277_s_at	159	0.003764	4.58	1.64-12.81
GSE2990	Distant metastasis free survival	201277_s_at	125	0.011967	3.55	1.32-9.53
GSE9195	Relapse free survival	201277_s_at	77	0.013795	9.13	1.57-53.10
GSE2990	Relapse free survival	201277_s_at	125	0.020474	2.37	1.14-4.93

Note: HR: hazard ratio; CI: confidence interval.